Nanobiotix

Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Source

Category
Software
Headquarters
Paris, France
Founded
2003

Nanobiotix across Glyph

Nanobiotix across Glyph: timeline

  1. Official Careers: nanobiotix.com/careers (Socials)
  2. Official RSS: nanobiotix.com/feed/ (Socials)
  3. Official LinkedIn: nanobiotix (Socials)
  4. Official X: @Nanobiotix (Socials)
  5. company added: https://companies.fru.dev/companies/nanobiotix (Socials)
  6. Nanobiotix: Public follow-on offering $100M (Emerging)
  7. Nanobiotix prices an oversubscribed EUR 85M global offering (Emerging)
  8. First randomized Phase 2 data for JNJ-1900 in stage 3 lung cancer (Emerging)
  9. Nanobiotix: Royalty financing $71M (Emerging)
  10. European regulators reclassify NBTXR3 from device to medicinal product (Emerging)
  11. Nanobiotix amends its NBTXR3 licensing deal with Johnson & Johnson (Emerging)
  12. FDA accepts protocol for Phase 2 NBTXR3 study in stage 3 lung cancer (Emerging)

Sources